CIK 0001549595 · Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270838048
- Phone
- (415) 660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,000 | 38,610 | ||
| 2025-01-30 | van Houte Hans Chief Financial Officer | Option exercise | +3,750 | 42,360 | ||
| 2025-01-30 | van Houte Hans Chief Financial Officer | Sale | −2,557 | $19.81 | $51K | 39,803 |
| 2025-01-30 | van Houte Hans Chief Financial Officer | Sale | −254 | $20.33 | $5K | 39,549 |
| 2025-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,886 | 11,545 | ||
| 2025-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,000 | 10,000 | ||
| 2025-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −3,750 | 33,750 | ||
| 2025-01-02 | Ring Christine Chief Legal Officer | Option exercise 10b5-1 | +5,760 | $1.86 | $11K | 33,844 |
| 2025-01-02 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −5,760 | $19.50 | $112K | 28,084 |
| 2025-01-02 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,760 | 53,986 | ||
| 2024-12-02 | Ring Christine Chief Legal Officer | Option exercise 10b5-1 | +5,760 | $1.86 | $11K | 33,844 |
| 2024-12-02 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −5,760 | $21.73 | $125K | 28,084 |
| 2024-12-02 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,760 | 59,746 | ||
| 2024-11-04 | Ring Christine Chief Legal Officer | Option exercise 10b5-1 | +3,290 | $9.57 | $31K | 31,374 |
| 2024-11-04 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −3,290 | $25.00 | $82K | 28,084 |
| 2024-11-04 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,290 | 96,389 | ||
| 2024-11-01 | Ring Christine Chief Legal Officer | Option exercise 10b5-1 | +5,760 | $1.86 | $11K | 33,844 |
| 2024-11-01 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −5,760 | $24.28 | $140K | 28,084 |
| 2024-11-01 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,760 | 65,506 | ||
| 2024-11-01 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −3,546 | $24.28 | $86K | 33,724 |
Page 16 of 20 · 381 trades